儿科炎性肠病中的甲原体古生物与疾病类型和活动相关
Agata Anna Cisek1, Edyta Szymańska2, Aldona Wierzbicka-Rucińska3
1Department of Pathomorphology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-730 Warsaw, Poland.
重要肠道微生物 - - 甲原性古生物 - - 在患有儿科炎症性肠病 (IBD) 的儿童中显著减少,包括克罗恩氏病.
科学领域:
- 微生物学 微生物学
- 儿科胃肠病学 儿科胃肠病学
- 肠道微生物组研究研究
背景情况:
- 肠道微生物群失调与炎症性肠道疾病 (IBD) 有关.
- 关于甲基生物的研究有限,特别是在儿科IBD人群中.
- 甲基生物是古老生物,它们在肠道生态系统功能中发挥作用.
研究的目的:
- 在儿科IBD中量化总甲原体和特定子组 (Methanobrevibacter smithii,Methanosphaera stadtmanae,Methanomassiliicoccales).
- 为了将甲素丰富度与克罗恩病 (CD) 和性结肠炎 (UC) 的类型和活性相关联.
- 为了比较IBD患者的甲素水平与健康对照.
主要方法:
- 使用定量实时PCR测定便样本中的甲原丰度.
- 使用儿科克朗氏病活动指数 (PCDAI),儿科性结肠炎活动指数 (PUCAI) 和便calprotectin (FCP) 评估疾病活性.
- 积极/不活跃的CD和UC组之间的数据和对照组的数据进行了比较.
主要成果:
- 与对照人群相比,患有CD和UC的儿童的甲素总计数显着较低.
- 与对照组相比,UC患者的甲素患病率降低了.
- 不活跃的UC患者显示了较低的Methanobrevibacter smithii水平,以及Methanosphaera stadtmanae和FCP度之间的正相关性.
结论:
- 在儿科IBD中,肠道甲素的丰度发生显著变化.
- 甲素水平与儿童克罗恩病和性结肠炎的类型和疾病活性相关.
- 这些发现凸显了甲基生物在儿科IBD病理生理学中的潜在作用.
更多相关视频
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
相关概念视频
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
